HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
2.430
-0.060 (-2.41%)
Nov 4, 2024, 4:00 PM EST - Market closed
HeartBeam Employees
HeartBeam had 15 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,127,400
Market Cap
64.55M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 15 | 0 | - |
| Dec 31, 2022 | 15 | 10 | 200.00% |
| Dec 31, 2021 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Atara Biotherapeutics | 225 |
| Prelude Therapeutics | 128 |
| Xilio Therapeutics | 73 |
| Boundless Bio | 72 |
| Syros Pharmaceuticals | 68 |
| InspireMD | 66 |
| Forian | 37 |
| Citius Pharmaceuticals | 22 |
BEAT News
- 4 days ago - HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time - Business Wire
- 11 days ago - HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards - Business Wire
- 18 days ago - HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization - Business Wire
- 5 weeks ago - HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist - Business Wire
- 7 weeks ago - HeartBeam Names Timothy Cruickshank as Chief Financial Officer - Business Wire
- 2 months ago - HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - HeartBeam Reports Second Quarter 2024 Results - Business Wire
- 3 months ago - HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time - Business Wire